Kathrin Bernt received an MD (summa cum laude) from Humboldt University in Berlin, Germany. She completed 2 years of training in pediatric Hematology/Oncology in Berlin, Germany, a major site of the BFM trials. She went on to complete a postdoctoral fellowship with Andre Lieber in Medical Genetics at the University of Washington. She completed an internship and residency in Pediatrics at Seattle Children’s Hospital / University of Washington and Texas Children’s Hospital / Baylor College of Medicine, and a Pediatric Hematology/Oncology Fellowship at Boston Children’s Hospital / Dana Farber Cancer Institute / Harvard Medical School.
Her clinical interests lie in hematologic malignancies and bone marrow transplantation. Her research focuses on understanding molecular mechanisms of hematopoietic and leukemia development and the discovery of new therapeutic approaches.
Kathrin Bernt received the 2010 SIOP award of Translational Research from the International Society of Paediatric Oncology (Societe Internationale D’oncologie Pediatrique – SIOP). In 2013, she received the ASCI Council's 2013 Young Physician-Scientist Awards at the Annual Meeting of the American Society of Clinical Investigation, Chicago, IL.
In her free time, she enjoys spending time with her two children, hiking, skiing, and riding horses.